Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CUL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KMT2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA0368 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRPM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINA10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM122C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TRIM44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRRD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAGLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TBCB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SF3B5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC4A11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COMT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSTO2P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPRS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VMO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on